GARDEN CITY, NY - Beyond Air, Inc. (NASDAQ:XAIR), a medical device company specializing in the design and development of therapeutic products, has entered into a sales agreement to potentially sell up ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want ...

OnCusp Therapeutics receives US FDA fast track designation for CUSP06 for treatment of platinum-resistant ovarian cancer: Princeton, New Jersey Saturday, February 15, 2025, 15:00 ...

NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company"), a medical technology company specializing in non-invasive therapeutic devices, today announced the completion of the acquisition of ENvue Medical ...

NanoVibronix (NAOV) announced the completion of the acquisition of ENvue Medical Holdings. The company said, “This strategic transaction will ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% Upside As ...

Gospel Oak School – based on Bilston Road in Tipton and part of the Central Region Schools Trust – has opened a new ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

The company has a debt-to-equity ratio of 0.48, a current ratio of 1.04 and a quick ... The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as ...